Protagonist Therapeutics Inc buy SVB Leerink LLC
Start price
19.03.26
/
50%
€88.00
Target price
19.03.27
€95.74
Performance (%)
-3.98%
Price
10.04.26
€84.50
Summary
This prediction is currently active. With a performance of -3.98%, the BUY prediction for Protagonist Therapeutics Inc by SVB_Leerink_LLC is down slightly. This prediction currently runs until 19.03.27. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Protagonist Therapeutics Inc | -5.587% |
| iShares Core DAX® | 2,55 % |
| iShares Nasdaq 100 | 2,74 % |
| iShares Nikkei 225® | 6,58 % |
| iShares S&P 500 | 1,93 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (PTGX) had its price target raised by Leerink Partners from $107.00 to $110.00. They now have an "outperform" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by SVB_Leerink_LLC for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€53.00
12.09.25
12.09.25
€62.24
12.09.26
12.09.26
59.43%
10.04.26
10.04.26

